Skip to Content
You are currently on the new version of our website. Access the old version .
  • Case Report
  • Open Access

5 December 2018

3 Pages

A Case of Invasive Pulmonary Aspergillosis during Treatment for Acute Exacerbation of Interstitial Lung Disease

and
1
Department of Respiratory Medicine, Nagoya Tokushukai General Hospital, 2-52 Kozoji-cho-kita, Kasugai 487-0016, Japan
2
Department of Thoracic Surgery, Nagoya Tokushukai General Hospital, Japan
*
Author to whom correspondence should be addressed.

Abstract

Prolonged immunosuppressive therapy is a risk factor for invasive pulmonary aspergillosis. We report a case of a 79-yearold man who underwent immunosuppressive therapy with methylprednisolone and cyclosporine for an acute exacerbation of interstitial lung disease. Ten days after initiation of immunosuppressive therapy, the patient reported night sweats and purulent sputum, and chest computed tomography scan revealed consolidation. He was diagnosed with invasive pulmonary aspergillosis, and required vasopressor support with oxygen therapy. After the administration of voriconazole and the modulation of immunosuppressive therapy, his condition improved. Short-term immunosuppressive therapy can also induce invasive pulmonary aspergillosis.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.